Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merlin Robb

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
The Journal of Infectious Diseases|June 6, 2018
Normalization of Soluble CD163 Levels After Institution of Antiretroviral Therapy During Acute HIV Infection Tracks with Fewer Neurological AbnormalitiesMichelle L D'Antoni, Mary Margaret Byron, Phillip Chan, et al.
Vaccine|August 26, 2011
Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in TanzaniaMuhammad Bakari, Said Aboud, Charlotta Nilsson, et al.
Cell Reports|November 29, 2023
High frequency of HIV precursor-target-specific B cells in sub-Saharan populationsFlavio Matassoli, Alberto Cagigi, Chen-Hsiang Shen, et al.
Journal of Virus Eradication|February 19, 2016
Virological and immunological characteristics of HIV-infected individuals at the earliest stage of infectionJintanat Ananworanich, Carlo P Sacdalan, Suteeraporn Pinyakorn, et al.
AIDS Research and Human Retroviruses|December 19, 2002
Molecular Epidemiology of HIV Type 1 in Ecuador, Peru, Bolivia, Uruguay, and ArgentinaJesse Hierholzer, Silvia Montano, Michael Hoelscher, et al.
JCI Insight|July 23, 2016
Impact of early cART in the gut during acute HIV infectionClaire Deleage, Alexandra Schuetz, W Gregory Alvord, et al.
Frontiers in Immunology|December 29, 2022
Fc receptor engagement of HIV-1 Env-specific antibodies in mothers and infants predicts reduced vertical transmissionBrittani M Barrows, Shelly J Krebs, Ningbo Jian, et al.
The Journal of Infectious Diseases|August 30, 2014
Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responsesGenevieve G Fouda, Coleen K Cunningham, Elizabeth J McFarland, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
The Journal of Infectious Diseases|June 6, 2018
Normalization of Soluble CD163 Levels After Institution of Antiretroviral Therapy During Acute HIV Infection Tracks with Fewer Neurological AbnormalitiesMichelle L D'Antoni, Mary Margaret Byron, Phillip Chan, et al.
Vaccine|August 26, 2011
Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in TanzaniaMuhammad Bakari, Said Aboud, Charlotta Nilsson, et al.
Cell Reports|November 29, 2023
High frequency of HIV precursor-target-specific B cells in sub-Saharan populationsFlavio Matassoli, Alberto Cagigi, Chen-Hsiang Shen, et al.
Journal of Virus Eradication|February 19, 2016
Virological and immunological characteristics of HIV-infected individuals at the earliest stage of infectionJintanat Ananworanich, Carlo P Sacdalan, Suteeraporn Pinyakorn, et al.
AIDS Research and Human Retroviruses|December 19, 2002
Molecular Epidemiology of HIV Type 1 in Ecuador, Peru, Bolivia, Uruguay, and ArgentinaJesse Hierholzer, Silvia Montano, Michael Hoelscher, et al.
JCI Insight|July 23, 2016
Impact of early cART in the gut during acute HIV infectionClaire Deleage, Alexandra Schuetz, W Gregory Alvord, et al.
Frontiers in Immunology|December 29, 2022
Fc receptor engagement of HIV-1 Env-specific antibodies in mothers and infants predicts reduced vertical transmissionBrittani M Barrows, Shelly J Krebs, Ningbo Jian, et al.
The Journal of Infectious Diseases|August 30, 2014
Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responsesGenevieve G Fouda, Coleen K Cunningham, Elizabeth J McFarland, et al.
Pageof 4